A spate of resignations and a slump in sales, largely as a result of the effects of Covid-19 in China, have characterised a challenging year at medical device maker TruScreen.
However, the company did report pockets of success, with clinical trials taking place across wider Asia and Mexico and a
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
